Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 2
1974 1
1976 4
1977 7
1978 3
1979 5
1981 1
1982 2
1983 2
1984 4
1985 4
1986 9
1987 2
1988 7
1989 4
1990 6
1991 18
1992 26
1993 17
1994 15
1995 19
1996 19
1997 18
1998 14
1999 11
2000 17
2001 26
2002 27
2003 23
2004 32
2005 40
2006 39
2007 37
2008 49
2009 56
2010 55
2011 75
2012 75
2013 90
2014 93
2015 111
2016 127
2017 118
2018 116
2019 112
2020 135
2021 163
2022 188
2023 134

Text availability

Article attribute

Article type

Publication date

Search Results

1,945 results

Results by year

Filters applied: . Clear all
Page 1
Idiopathic inflammatory myopathies.
Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW. Lundberg IE, et al. Among authors: aggarwal r. Nat Rev Dis Primers. 2021 Dec 2;7(1):86. doi: 10.1038/s41572-021-00321-x. Nat Rev Dis Primers. 2021. PMID: 34857798 Review.
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
COVID-19 and Myositis: What We Know So Far.
Saud A, Naveen R, Aggarwal R, Gupta L. Saud A, et al. Among authors: aggarwal r. Curr Rheumatol Rep. 2021 Jul 3;23(8):63. doi: 10.1007/s11926-021-01023-9. Curr Rheumatol Rep. 2021. PMID: 34216297 Free PMC article. Review.
Antisynthetase syndrome: A distinct disease spectrum.
Huang K, Aggarwal R. Huang K, et al. Among authors: aggarwal r. J Scleroderma Relat Disord. 2020 Oct;5(3):178-191. doi: 10.1177/2397198320902667. Epub 2020 Feb 18. J Scleroderma Relat Disord. 2020. PMID: 35382516 Free PMC article. Review.
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Herberts C, Annala M, Sipola J, Ng SWS, Chen XE, Nurminen A, Korhonen OV, Munzur AD, Beja K, Schönlau E, Bernales CQ, Ritch E, Bacon JVW, Lack NA, Nykter M, Aggarwal R, Small EJ, Gleave ME; SU2C/PCF West Coast Prostate Cancer Dream Team; Quigley DA, Feng FY, Chi KN, Wyatt AW. Herberts C, et al. Among authors: aggarwal r. Nature. 2022 Aug;608(7921):199-208. doi: 10.1038/s41586-022-04975-9. Epub 2022 Jul 20. Nature. 2022. PMID: 35859180
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Sjöström M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY. Sjöström M, et al. Among authors: aggarwal r. Cancer Res. 2022 Nov 2;82(21):3888-3902. doi: 10.1158/0008-5472.CAN-22-1123. Cancer Res. 2022. PMID: 36251389 Free PMC article.
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.
Gonzalez D, Gupta L, Murthy V, Gonzalez EB, Williamson KA, Makol A, Tan CL, Sulaiman FN, Shahril NS, Isa LM, Martín-Nares E, Aggarwal R. Gonzalez D, et al. Among authors: aggarwal r. Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4. Rheumatol Int. 2022. PMID: 35661906 Free PMC article. Review.
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. Yao J, et al. Among authors: aggarwal r. Oncologist. 2022 Nov 3;27(11):940-951. doi: 10.1093/oncolo/oyac161. Oncologist. 2022. PMID: 35983951 Free PMC article. Review.
Defining anti-synthetase syndrome: a systematic literature review.
Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Monteccucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Selva-O'Callaghan A, Werth VP, Sakellariou G, Aggarwal R, Cavagna L. Zanframundo G, et al. Among authors: aggarwal r. Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25. Clin Exp Rheumatol. 2022. PMID: 35225224 Free PMC article.
1,945 results